Draft Evidence Report on treatments for high cholesterol

Draft Evidence Report on treatments for high cholesterol

On November 12, 2020, ICER released its Draft Evidence Report entitled, “Bempedoic Acid and Inclisiran for Patients with Heterozygous Familial Hypercholesterolemia and for Secondary Prevention of ASCVD: Effectiveness and Value.”  Patients Rising Now submitted comments...
Draft Evidence Report on treatments for Hemophilia A

Draft Evidence Report on treatments for Hemophilia A

On August 26, 2020, ICER released its Draft Evidence Report entitled, “Valoctocogene Roxaparvovec and Emicizumab for Hemophilia A.”  Patients Rising Now submitted comments on the draft report raising a number of concerns about both the substance of the...

Ulcerative Colitis

Patients Rising Now Comments on ICER Draft Evidence Report: “Targeted Immune Modulators for Ulcerative Colitis: Effectiveness and...
JAK Inhibitors for Rheumatoid Arthritis: Draft Evidence Report

JAK Inhibitors for Rheumatoid Arthritis: Draft Evidence Report

Patients Rising Now appreciates the opportunity to provide our comments on ICER’s October 11th Draft Evidence Report “Janus Kinase Inhibitors for Rheumatoid Arthritis.” We are also encouraged that ICER delayed the release of the draft report to revise and update its...